Human GIP(3-30)NH 2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors-Reference-Cited by-同舟云学术

Human GIP(3-30)NH 2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

Published:2018-04 Issue: Volume:150 Page:97-107
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Gabe Maria Buur Nordskov,Sparre-Ulrich Alexander Hovard,Pedersen Mie Fabricius,Gasbjerg Lærke Smidt,Inoue Asuka,Bräuner-Osborne Hans,Hartmann Bolette,Rosenkilde Mette Marie

Funder

Novo Nordisk Foundation

Independent Research Fund Denmark

Medical Sciences and the Carlsberg Foundation

Japan Science and Technology, PRESTO

Japan Society for the Promotion of Science, KAKENHI

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference61 articles.

1. The effect of atropine on plasma gastric inhibitory polypeptide (GIP), serum insulin, and blood glucose after intraduodenal infusion of fat;Jorde;Scand. J. Gastroenterol.,1981

2. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion;Thomas;Gastroenterology,1976

3. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans;Rayner;Am. J. Physiol. – Regul., Integ. Compar. Physiol.,2000

4. Stimulation of insulin secretion by gastric inhibitory polypeptide in man;Dupre;J. Clin. Endocrinol. Metab.,1973

5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7–36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J. Clin. Endocrinol. Metab.,1993

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys;Molecular Metabolism;2024-10

2. GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly;The Journal of Clinical Endocrinology & Metabolism;2024-08-22

3. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

4. GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology;Peptides;2024-07

5. Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge;British Journal of Pharmacology;2024-07